February 14, 2019
The 2nd Annual Companion Diagnostics & Biomarkers 2019 will provide valued information about new IVD regulations, Dx reimbursement strategy, market access strategy to ensure successful commercialization with pharma & biotech companies.
February 14, 2019
Biobanking 2018 is the leading event to get through the biobanking’s ever-thriving market and convenes key stakeholders from the field, and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biobanking product success.
March 21, 2019
Biosimilars & Biologics 2019 is the leading event to continually stay on the pulse of the biosimilars’ ever-changing market and convenes key stakeholders including biosimilar and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biosimilar product success
New York, USA
April 11, 2019
Inhalation & Respiratory Drug Delivery 2019 will focus on the challenges of bringing respiratory products to market and innovative aerosol science, including modelling and toxicology. Presentations will also feature key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis.
Orphan Drugs for Rare Diseases 2019 will help connect industry professionals internationally, ensuring there is a great networking and learning opportunity to share knowledge of research, developments and issues.
Pre-Filled Syringes 2019 will explore the advancements in regulatory guidelines, product development, manufacturing processes, risk mitigation, portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology, connectivity, speed to market, and next generation syringes.
Drug Delivery & Formulation 2019 provides drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are and presents a strategic level program for pharma and business development professionals
September 26, 2019
Liquid Biopsy 2019 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.